In the latest trading session,, 0.55 million Sagimet Biosciences Inc (NASDAQ:SGMT) shares changed hands as the company’s beta touched 2.29. With the company’s most recent per share price at $5.57 changing hands around $0.01 or 0.18% at last look, the market valuation stands at $170.85M. SGMT’s current price is a discount, trading about -32.5% off its 52-week high of $7.38. The share price had its 52-week low at $1.73, which suggests the last value was 68.94% up since then.
Analysts gave the Sagimet Biosciences Inc (SGMT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended SGMT as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
Sagimet Biosciences Inc (NASDAQ:SGMT) trade information
Instantly SGMT is in green as seen in intraday trades today. With action 59.60%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 23.78%, with the 5-day performance at 59.60% in the green. However, in the 30-day time frame, Sagimet Biosciences Inc (NASDAQ:SGMT) is 74.06% up.
The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 7.17% from its recent market value. According to analyst projections, SGMT’s forecast low is 6 with 6 as the target high. To hit the forecast high, the stock’s price needs a -7.72% plunge from its current level, while the stock would need to soar -7.72% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -16.85%. The 2025 estimates are for Sagimet Biosciences Inc earnings to decrease by -74.49%.
SGMT Dividends
Sagimet Biosciences Inc is expected to release its next quarterly earnings report in July.
NEA MANAGEMENT COMPANY, LLC holds the second largest percentage of outstanding shares, with 6.2677% or 2.0 million shares worth $6.84 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and BlackRock Health Sciences Term Trust . With 763.99 shares estimated at $4.07 million under it, the former controlled 2.49% of total outstanding shares. On the other hand, BlackRock Health Sciences Term Trust held about 1.33% of the shares, roughly 408.12 shares worth around $2.18 million.
